Liu G, Pessah I N
Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis 95616.
J Biol Chem. 1994 Dec 30;269(52):33028-34.
The fluorogenic maleimide 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin (CPM) has been shown to selectively form Michael adducts with hyperreactive sulfhydryls on the skeletal sarcoplasmic reticulum (SR) ryanodine receptor (RyR1) and triadin which are essential for normal Ca2+ channel function (Liu, G., Abramson, J.J., Zable, A.C., and Pessah, I.N. (1994) Mol. Pharmacol. 45, 189-200). The present report demonstrates a functionally important interaction between RyR1 and triadin which involves, in part, redox cycling of hyperreactive sulfhydryls in response to channel activation and inactivation. Nanomolar CPM is shown to selectively label RyR1 and triadin only in the presence of Ca2+ channel inhibitors (Mg2+, neomycin, ruthenium red, or anti-triadin antibody). Treatment of SR with channel activators (micromolar Ca2+, nanomolar ryanodine, or millimolar caffeine), 1) slows CPM labeling kinetics > 10-fold, 2) negates CPM labeling of channel-associated sulfhydryls, and 3) stabilizes a high molecular weight complex (HMWC) which appears on nonreducing SDS-polyacrylamide gel electrophoresis gels. The HMWC is positively identified as RyR1 and triadin by Western blot and immunoprecipitation analyses. High-affinity [3H]ryanodine-binding sites are immunoprecipitated by either anti-RyR1 or anti-triadin antibody dose dependently. 1,4-Naphthoquinone (< or = 40 pmol/micrograms protein) selectively oxidizes hyperreactive sulfhydryls on RyR1 and triadin, induces Ca2+ efflux from SR, and stabilizes the HMWC. The HMWC is reduced by beta-mercaptoethanol or dithiothreitol into its component RyR1 and triadin promoters. The results provide direct evidence for the existence of a functionally important complex between RyR1 and triadin whose stability is determined by the redox state of hyperreactive sulfhydryl moieties which are allosterically regulated by physiological and pharmacological channel ligands. The present results suggest a possible molecular mechanism by which localized transient changes in the redox state within the RyR1-triadin complex can signal information across the SR membrane.
荧光马来酰亚胺7 - 二乙氨基 - 3 -(4'-马来酰亚胺基苯基)- 4 - 甲基香豆素(CPM)已被证明能与骨骼肌肌浆网(SR)兰尼碱受体(RyR1)和三联蛋白上的高反应性巯基选择性地形成迈克尔加成物,而这些对于正常的Ca2 +通道功能至关重要(Liu, G., Abramson, J.J., Zable, A.C., and Pessah, I.N. (1994) Mol. Pharmacol. 45, 189 - 200)。本报告证明了RyR1和三联蛋白之间存在功能上重要的相互作用,这部分涉及高反应性巯基响应通道激活和失活的氧化还原循环。已表明,仅在存在Ca2 +通道抑制剂(Mg2 +、新霉素、钌红或抗三联蛋白抗体)的情况下,纳摩尔浓度的CPM能选择性标记RyR1和三联蛋白。用通道激活剂(微摩尔浓度的Ca2 +、纳摩尔浓度的兰尼碱或毫摩尔浓度的咖啡因)处理SR,1)使CPM标记动力学减慢10倍以上,2)消除通道相关巯基的CPM标记,3)稳定在非还原SDS - 聚丙烯酰胺凝胶电泳凝胶上出现的高分子量复合物(HMWC)。通过蛋白质免疫印迹和免疫沉淀分析,HMWC被明确鉴定为RyR1和三联蛋白。抗RyR1或抗三联蛋白抗体均剂量依赖性地免疫沉淀高亲和力的[3H]兰尼碱结合位点。1,4 - 萘醌(≤40 pmol/μg蛋白质)选择性氧化RyR1和三联蛋白上的高反应性巯基,诱导Ca2 +从SR流出,并稳定HMWC。HMWC被β - 巯基乙醇或二硫苏糖醇还原为其组成成分RyR1和三联蛋白启动子。这些结果为RyR1和三联蛋白之间存在功能上重要的复合物提供了直接证据,其稳定性由高反应性巯基部分的氧化还原状态决定,而高反应性巯基部分受生理和药理通道配体的变构调节。目前的结果提示了一种可能的分子机制,通过该机制,RyR1 - 三联蛋白复合物内氧化还原状态的局部瞬时变化可以跨SR膜传递信息。